Barcelona 2015 Programme Registration Glaucoma Day 2015 Exhibition Virtual Exhibition Satellite Meetings Hotel Booking Star Alliance
ISTANBUL escrs









Take a look inside the London 2014 Congress

video-icon

Then register to join us
in Barcelona!





Posters

Search Abstracts by author or title
(results will display both Free Papers & Poster)

Postoperative distance best corrected visual acuity with the WaveLight refractive suite (Excimer EX500 and Femtosecond FS200 lasers)

Poster Details

First Author: M.Maus GERMANY

Co Author(s):    A. Cummings   D. Durrie   M. Gordon   R. Williams   J. Gow        

Abstract Details

Purpose:

To evaluate postoperative distance best corrected visual acuity (BCVA) after LASIK treatment for myopia using the WaveLight Refractive Suite.

Setting:

Prospective, post-market, and open label clinical trial at 4 sites, 2 sites each in US and Europe. 1. Durrie Vision, Overland Park KS, USA 2. Gordon-Weiss-Schanzlin Vision Institute, San Diego CA, USA 3. Wellington Eye Clinic, Dublin, Ireland 4. Sehkraft Augenzentrum Maus, Cologne, Germany

Methods:

Myopic subjects 18 years of age or older underwent LASIK treatment with the WaveLight Refractive Suite. Subjects completed visits preoperatively and at 1 day, 1 month, 3 months, and 6 months postoperatively. Monocular manifest refraction and BCVA was measured with an ETDRS chart at 4 meters.

Results:

Ninety-seven subjects underwent LASIK treatment and 96 subjects were included in the full analysis set. The mean manifest refraction spherical equivalent at baseline was -3.67 D ±1.98 D. Compared to baseline, a gain of 1 or more line in distance BCVA was demonstrated in 52% of eyes at 1 month, 57% of eyes at the 3 months, and 60% of eyes at 6 months. No eyes lost two or more lines in BCVA at any postoperative visit.

Conclusions:

The majority of the subjects’ eyes had a 1 line gain of distance BCVA at 1 month, 3 months, and 6 months postoperatively compared to baseline. The percentage of eyes with a gain of one or more line increased between consecutive postoperative visits.

Financial Disclosure:

One or more of the authors is employed by a for-profit company with an interest in the subject of the presentation, One or more of the authors receives consulting fees, retainer, or contract payments from a company producing, developing or supplying the product or procedure presented

Back to Poster listing